Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1344 ARTÍCULOS , VIENDO DEL 421 AL 435

Alzheimer's disease

De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV.

Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14.

Analysis of copy number variation in Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals

Swaminathan S, Huentelman MJ, Corneveaux JJ, Myers AJ, Faber KM, Foroud T, Mayeux R, Shen L, Kim S, Turk M, Hardy J, Reiman EM, Saykin AJ; Alzheimer's Disease Neuroimaging Initiative and NIA-LOAD/NCRAD Family Study Group.

PLoS One. 2012;7(12):e50640. doi: 10.1371/journal.pone.0050640. Epub 2012 Dec 5.

Rationale for combining glutamatergic and cholinergic approaches in the symptomatic treatment of Alzheimer's disease

Francis PT, Parsons CG, Jones RW.

Expert Rev Neurother. 2012 Nov;12(11):1351-65. doi: 10.1586/ern.12.124.

Brain gene expression of a sporadic (icv-STZ Mouse) and a familial mouse model (3xTg-AD mouse) of Alzheimer's disease

Chen Y, Tian Z, Liang Z, Sun S, Dai CL, Lee MH, LaFerla FM, Grundke-Iqbal I, Iqbal K, Liu F, Gong CX.

PLoS One. 2012;7(12):e51432. doi: 10.1371/journal.pone.0051432. Epub 2012 Dec 7.

An overview on potential neuroprotective compounds for management of Alzheimer's disease

Sheikh IA, Ali R, Dar TA, Kamal MA.

CNS Neurol Disord Drug Targets. 2012 Dec;11(8):1006-11. doi: 10.2174/1871527311211080010.

[Mitochondrial enzyme ABAD and its role in the development and treatment of Alzheimer's disease]

Benek O, Musílek K, Kuca K.

Ceska Slov Farm. 2012 Aug;61(4):144-9.

Effects of long-term treatment with pioglitazone on cognition and glucose metabolism of PS1-KI, 3xTg-AD, and wild-type mice

Masciopinto F, Di Pietro N, Corona C, Bomba M, Pipino C, Curcio M, Di Castelnuovo A, Ciavardelli D, Silvestri E, Canzoniero LM, Sekler I, Pandolfi A, Sensi SL.

Cell Death Dis. 2012 Dec 20;3(12):e448. doi: 10.1038/cddis.2012.189.

[Tacrine and its derivatives in the therapy of Alzheimers disease]

Korábečný J, Spilovská K, Benek O, Musílek K, Soukup O, Kuča K.

Ceska Slov Farm. 2012 Oct;61(5):210-21.

Rheumatoid arthritis and Alzheimer's disease: genetic and epigenetic links in inflammatory regulation

Ferraccioli G, Carbonella A, Gremese E, Alivernini S.

Discov Med. 2012 Dec;14(79):379-88.

Curcuminoids and resveratrol as anti-Alzheimer agents

Villaflores OB, Chen YJ, Chen CP, Yeh JM, Wu TY.

Taiwan J Obstet Gynecol. 2012 Dec;51(4):515-25. doi: 10.1016/j.tjog.2012.09.005.

Pain in people with Alzheimer disease: potential applications for psychophysical and neurophysiological research

Monroe TB, Gore JC, Chen LM, Mion LC, Cowan RL.

J Geriatr Psychiatry Neurol. 2012 Dec;25(4):240-55. doi: 10.1177/0891988712466457. Epub 2012 Dec 31.

[The reliability and validity of Chinese version of AD8]

Li T, Wang HL, Yang YH, Galvin JE, Morris JC, Yu X.

Zhonghua Nei Ke Za Zhi. 2012 Oct;51(10):777-80.

[Advance in study on endogenous formaldehyde and pathogenesis of Alzheimer's disease]

Li WW, Guo H, Fan GW, Wang XM.

Zhongguo Zhong Yao Za Zhi. 2012 Oct;37(20):3017-20.

Ischemia signalling to Alzheimer-related genes

Pluta R, Kocki J, Maciejewski R, Ułamek-Kozioł M, Jabłoński M, Bogucka-Kocka A, Czuczwar SJ.

Folia Neuropathol. 2012;50(4):322-9. doi: 10.5114/fn.2012.32362.

Higher-dose (23 mg/day) donepezil formulation for the treatment of patients with moderate-to-severe Alzheimer's disease

Christensen DD.

Postgrad Med. 2012 Nov;124(6):110-6. doi: 10.3810/pgm.2012.11.2589.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias